Antipyrine as a dialyzable reference to correct differences in efficiency among and within sampling devices during in vivo microdialysis.

Antipyrine was investigated as a dialyzable substance that could be used to quantitate relative differences in the efficiency of dialysis among multiple microdialysis probes and by a single probe over time. The contribution of effective membrane surface area to recovery variability was tested by the introduction of air into microdialysis probes. Reduction of effective membrane surface area reduced antipyrine recovery. Dialysates from probes implanted in the jugular vein, brain, and liver of rats receiving antipyrine demonstrated differences in antipyrine concentration among probes within the same rat. These results suggest dissimilar efficiencies of the probes to recover antipyrine, which should be uniformly distributed throughout body water. Dialysates from blood, brain, and liver probes in rats that received both antipyrine and tritiated water (3H2O) showed differences in antipyrine and 3H2O concentrations among probes. Variability of antipyrine and 3H2O concentrations over time within a probe were positively correlated, suggesting that the cause(s) of temporal variability affected both of these markers of body water. Correction of antipyrine tissue/blood ratios, using 3H2O blood/tissue ratios from the same sampling period, reduced the variability in antipyrine tissue/blood ratios, producing ratios closer to the expected value of 1. Differences in probe efficiency contributing to the variability of antipyrine and 3H2O recovery would also be expected to influence the recovery of other substances during microdialysis. The administration of antipyrine during microdialysis experiments is suggested to enable reduction of temporal and site-related differences in substance recovery that are due to differences in probe efficiency. Other methods are necessary to determine the actual extracellular concentration of dialyzed substances and the integrity of the blood-brain barrier.

[1]  P F Morrison,et al.  Steady-state theory for quantitative microdialysis of solutes and water in vivo and in vitro. , 1990, Life sciences.

[2]  U. Ungerstedt,et al.  Aluminum distribution into brain and liver of rats and rabbits following intravenous aluminum lactate or citrate: a microdialysis study. , 1991, Toxicology and applied pharmacology.

[3]  U. Ungerstedt,et al.  A comparison between three methods for estimation of extracellular concentrations of exogenous and endogenous compounds by microdialysis. , 1991, Journal of pharmacological methods.

[4]  D. Rall,et al.  Distribution of drugs between blood and cerebrospinal fluid: general methodology and effect of pH gradients. , 1959, The Journal of pharmacology and experimental therapeutics.

[5]  P. McNamara,et al.  Phenobarbital in the genetically obese Zucker rat. II. In vivo and in vitro assessments of microsomal enzyme induction. , 1984, The Journal of pharmacology and experimental therapeutics.

[6]  G. Levy,et al.  Inhibition of drug metabolism by hydroxylated metabolites: cross-inhibition and specificity. , 1975, Journal of pharmaceutical sciences.

[7]  O. Major,et al.  Continuous monitoring of blood-brain barrier opening to Cr51-EDTA by microdialysis following probe injury. , 1990, Acta neurochirurgica. Supplementum.

[8]  G R Wilkinson,et al.  Prediction of hepatic extraction ratio from in vitro measurement of intrinsic clearance. , 1977, The Journal of pharmacology and experimental therapeutics.

[9]  W. Vogel,et al.  Continuous monitoring of brain ethanol levels by intracerebral microdialysis. , 1990, Alcohol.

[10]  C. Freed,et al.  Brain acetaminophen measurement by in vivo dialysis, in vivo electrochemistry and tissue assay: a study of the dialysis technique in the rat , 1988, Journal of Neuroscience Methods.

[11]  U. Ungerstedt,et al.  Microdialysis in the study of extracellular levels of amino acids in the rat brain. , 1986, Acta physiologica Scandinavica.

[12]  R. Yokel,et al.  Dissimilar Aluminum and Gallium Permeation of the Blood‐Brain Barrier Demonstrated by In Vivo Microdialysis , 1992, Journal of neurochemistry.

[13]  G R Wilkinson,et al.  Plasma binding and transport of diazepam across the blood-brain barrier. No evidence for in vivo enhanced dissociation. , 1989, The Journal of clinical investigation.

[14]  P. McNamara,et al.  Pharmacokinetics of acetaminophen, antipyrine, and salicylic acid in the lactating and nursing rabbit, with model predictions of milk to serum concentration ratios and neonatal dose. , 1991, Toxicology and applied pharmacology.

[15]  M. Brennan,et al.  Total body water and the exchangeable hydrogen. II. A review of comparative data from animals based on isotope dilution and desiccation, with a report of new data from the rat. , 1977, The American journal of physiology.

[16]  H. Benveniste,et al.  Elevation of the Extracellular Concentrations of Glutamate and Aspartate in Rat Hippocampus During Transient Cerebral Ischemia Monitored by Intracerebral Microdialysis , 1984, Journal of neurochemistry.

[17]  U. Ungerstedt,et al.  In Vivo Microdialysis as a Technique to Monitor Drug Transport: Correlation of Extracellular Cocaine Levels and Dopamine Overflow in the Rat Brain , 1988, Journal of neurochemistry.

[18]  S. L. Chang,et al.  Characterization of antipyrine autoinduction in the rat utilizing a new microsampling technique for serial blood sample collections. , 1986, Journal of pharmaceutical sciences.

[19]  C I Larsson,et al.  The use of an "internal standard" for control of the recovery in microdialysis. , 1991, Life sciences.

[20]  Joseph B. Justice,et al.  Extracellular cocaine and dopamine concentrations are linearly related in rat striatum , 1988, Brain Research.